Next Article in Journal
Pathotypes of Xanthomonas axonopodis pv. dieffenbachiae Isolated from Anthurium andraeanum in China
Next Article in Special Issue
Host-Driven Phosphorylation Appears to Regulate the Budding Activity of the Lassa Virus Matrix Protein
Previous Article in Journal
Armillaria Root-Rot Pathogens: Species Boundaries and Global Distribution
Article Menu

Export Article

Open AccessReview
Pathogens 2018, 7(4), 84; https://doi.org/10.3390/pathogens7040084

Improving the Breadth of the Host’s Immune Response to Lassa Virus

Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD 21201, USA
*
Author to whom correspondence should be addressed.
Received: 21 September 2018 / Revised: 20 October 2018 / Accepted: 24 October 2018 / Published: 28 October 2018
Full-Text   |   PDF [1111 KB, uploaded 31 October 2018]   |  

Abstract

In 2017, the global Coalition for Epidemic Preparedness (CEPI) declared Lassa virus disease to be one of the world’s foremost biothreats. In January 2018, World Health Organization experts met to address the Lassa biothreat. It was commonly recognized that the diversity of Lassa virus (LASV) isolated from West African patient samples was far greater than that of the Ebola isolates from the West African epidemic of 2013–2016. Thus, vaccines produced against Lassa virus disease face the added challenge that they must be broadly-protective against a wide variety of LASV. In this review, we discuss what is known about the immune response to Lassa infection. We also discuss the approaches used to make broadly-protective influenza vaccines and how they could be applied to developing broad vaccine coverage against LASV disease. Recent advances in AIDS research are also potentially applicable to the design of broadly-protective medical countermeasures against LASV disease. View Full-Text
Keywords: Lassa virus disease (LVD); vaccine breadth; mimicry; B cell anergy; conserved antigens; Fc-gamma receptors; conformational antigens; broadly-neutralizing antibodies; focused immunity; dominant and subdominant epitopes; cross-restriction Lassa virus disease (LVD); vaccine breadth; mimicry; B cell anergy; conserved antigens; Fc-gamma receptors; conformational antigens; broadly-neutralizing antibodies; focused immunity; dominant and subdominant epitopes; cross-restriction
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Zapata, J.C.; Medina-Moreno, S.; Guzmán-Cardozo, C.; Salvato, M.S. Improving the Breadth of the Host’s Immune Response to Lassa Virus. Pathogens 2018, 7, 84.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pathogens EISSN 2076-0817 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top